Patents by Inventor Qiangbo HOU

Qiangbo HOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230279407
    Abstract: The present disclosure relates to a recombinant nucleic acid molecule based on point mutation of translation initiation element and use thereof in the preparation of circular RNA, and in particular to a recombinant nucleic acid molecule for preparing circular RNA, a recombinant expression vector, circular RNA, a composition, a method for preparing circular RNA, a method for expressing a target polypeptide in a cell, a method for preventing or treating a disease, a method for editing a translation initiation element sequence, and a system for editing a translation initiation element sequence.
    Type: Application
    Filed: July 22, 2022
    Publication date: September 7, 2023
    Inventors: Qiangbo HOU, Zonghao QIU, Yang ZHAO, Chijian ZUO, Zhenhua SUN
  • Publication number: 20230279389
    Abstract: The present disclosure relates to a recombinant nucleic acid molecule and an application thereof in preparation of a circular RNA, and in particular, to a recombinant nucleic acid molecule for preparing a circular RNA, a recombinant expression vector, a circular RNA, a composition, a method for preparing a circular RNA, a method for expressing a target polypeptide in a cell, a method for screening a target coding region sequence, a system for screening a target coding region sequence, and a method for screening a ribozyme recognition site sequence.
    Type: Application
    Filed: July 22, 2022
    Publication date: September 7, 2023
    Inventors: Zonghao QIU, Qiangbo HOU, Yang ZHAO, Chijian ZUO, Zhenhua SUN
  • Publication number: 20230119715
    Abstract: The disclosure belongs to the technical field of bioinformatics and bioengineering, and specifically, relates to a Levenshtein distance-based IRES screening method, a polynucleotide screened based on this method, a circular nucleic acid molecule including the polynucleotide, a cyclization precursor nucleic acid molecule, a recombinant nucleic acid molecule, a recombinant expression vector, a recombinant host cell, and use. In the disclosure, averages of Levenshtein distances between all sample sequences and to-be-predicted sequences are compared, to efficiently and accurately determine whether there is an IRES in the to-be-predicted sequence, which has advantages of high efficiency and an accurate screening result.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 20, 2023
    Inventors: Qiangbo HOU, Jiafeng ZHU, Zonghao QIU, Chijian ZUO, Zhenhua SUN